Literature DB >> 3546519

Phage-associated cytotoxin production by and enteroadhesiveness of enteropathogenic Escherichia coli isolated from infants with diarrhea in West Germany.

H Karch, J Heesemann, R Laufs.   

Abstract

We assessed the frequency of isolating enteropathogenic Escherichia coli (EPEC) from the stools of infants with diarrhea, the enteroadhesiveness of the EPEC, their production of cytotoxin, and the association of cytotoxin synthesis with lysogenic phages. One hundred twenty-five isolates of EPEC obtained from 1,674 children with diarrhea; three were isolated from 868 controls. Thirty EPEC made elevated levels (greater than or equal to 10(4) 50% cytotoxic doses/mg of cell lysate protein) of a cytotoxin for HeLa cells, and cell-associated cytotoxicity for 27 of these isolates was neutralized by antibody to Shiga toxin. Cell lysates of these isolates were paralytic and lethal for mice. Phages from cytotoxin-producing strains were tested for toxin-converting capacity. Fifteen of 30 such strains harbored toxin-converting phages, and the cytotoxicity of 12 isolates of E. coli K12 transduced with these phages was neutralized by antibody to Shiga toxin. Fifty-seven EPEC exhibited either localized or diffuse adherence to HEp-2 cells, but only nine producers of elevated levels of cytotoxin were adherent.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3546519     DOI: 10.1093/infdis/155.4.707

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  21 in total

1.  Verotoxigenic (enterohaemorrhagic) Escherichia coli in infants and toddlers in Czechoslovakia.

Authors:  M Bielaszewská; L Srámková; J Janda; K Bláhová; H Ambrozová
Journal:  Infection       Date:  1990 Nov-Dec       Impact factor: 3.553

2.  Production of Shiga-like toxin among Escherichia coli strains and other bacteria isolated from diarrhea in São Paulo, Brazil.

Authors:  R Giraldi; B E Guth; L R Trabulsi
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

Review 3.  Shiga and Shiga-like toxins.

Authors:  A D O'Brien; R K Holmes
Journal:  Microbiol Rev       Date:  1987-06

4.  Nucleotide sequence analysis of enteropathogenic Escherichia coli (EPEC) adherence factor probe and development of PCR for rapid detection of EPEC harboring virulence plasmids.

Authors:  J Franke; S Franke; H Schmidt; A Schwarzkopf; L H Wieler; G Baljer; L Beutin; H Karch
Journal:  J Clin Microbiol       Date:  1994-10       Impact factor: 5.948

5.  The association of enterotoxigenic and enteropathogenic Escherichia coli and other enteric pathogens with childhood diarrhoea in Yugoslavia.

Authors:  M Cobeljić; D Mel; B Arsić; L Krstić; B Sokolovski; B Nikolovski; E Sopovski; M Kulauzov; S Kalenić
Journal:  Epidemiol Infect       Date:  1989-08       Impact factor: 2.451

6.  Vero cytotoxin-producing strains of Escherichia coli in children with haemolytic uraemic syndrome and diarrhoea in Czechoslovakia.

Authors:  L Srámková; M Bielaszewská; J Janda; K Bláhova; O Hausner
Journal:  Infection       Date:  1990 Jul-Aug       Impact factor: 3.553

7.  Evaluation of oligonucleotide probes for identification of shiga-like-toxin-producing Escherichia coli.

Authors:  H Karch; T Meyer
Journal:  J Clin Microbiol       Date:  1989-06       Impact factor: 5.948

8.  Differentiation in virulence patterns of Escherichia coli possessing eae genes.

Authors:  H Schmidt; B Plaschke; S Franke; H Rüssmann; A Schwarzkopf; J Heesemann; H Karch
Journal:  Med Microbiol Immunol       Date:  1994-02       Impact factor: 3.402

Review 9.  Adhesion and its role in the virulence of enteropathogenic Escherichia coli.

Authors:  D Law
Journal:  Clin Microbiol Rev       Date:  1994-04       Impact factor: 26.132

10.  The role of Escherichia coli O 157 infections in the classical (enteropathic) haemolytic uraemic syndrome: results of a Central European, multicentre study.

Authors:  M Bitzan; K Ludwig; M Klemt; H König; J Büren; D E Müller-Wiefel
Journal:  Epidemiol Infect       Date:  1993-04       Impact factor: 2.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.